Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity

Thrombosis Research

Volumn 119, Issue 4, 2007, Pages 475-480

  Pawlak, Krystyna ^a   Pawlak, Dariusz ^a   Mysliwiec, Michal ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Fibrinolytic activity; Haemodialysis; Peritoneal dialysis; Soluble uPAR

Indexed keywords

ANTIPLASMIN; PLASMIN; UROKINASE; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; UREMIA;

ADULT; ANTIPLASMIN; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PLASMIN; RECEPTORS, CELL SURFACE; RENAL DIALYSIS; SOLUBILITY; URINARY PLASMINOGEN ACTIVATOR;

EID: 33846428791     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.03.011     Document Type: Article

References (16)

1. Lijnen H.R., and Collen D. Mechanisms of physiological fibrinolysis. Bailliere's Clinical Hematology vol. 8 (1995), Bailliera Tindall, London, UK 277-290
2. Husain S.S. Single-chain urokinase-type plasminogen activator does not posses measurable intrinsic amidolytic or plasminogen activator activities. Biochemistry 30 (1991) 5707-5805
3. Kasai S., Arimura H., Nishida M., and Suyama T. Proteolytic cleavage of single chain prourokinase induces conformational change which follows activation of the zymogen and production of its high affinity to fibrin. J Biol Chem 260 (1985) 12382-12389
4. Higazi A.A.-R., Cohen R.L., Henkin J., Kniss D., Schwartz B.S., and Cines D.B. Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor. J Biol Chem 270 (1995) 17375-17380
5. Carmeliet P., Schoonjans L., Kieckens L., Ream B., Degen J., Bronson R., et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 369 (1994) 419-424
6. Yamamoto K., and Loskutoff D.J. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue type plasminogen activator. J Clin Invest 97 (1996) 2440-2451
7. Bugge T.H., Suh T.T., Flick M.J., Daugherty C.C., Romer J., Solberg H., et al. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem 270 (1995) 16886-16894
8. Ninomiya H., Hasegawa T., Nagasawa T., and Abe T. Excess soluble urokinase-type plasminogen activator receptor in the plasma of patients with paroxysomal nocturnal hemoglobinuria inhibits cell-associated fibrinolytic activity. Int J Hematol 65 (1997) 285-291
9. Pawlak K., Pawlak D., and Mysliwiec M. Oxidative stress effects fibrinolytic system in dialysis uraemic patients. Thromb Res 117 (2006) 517-522
10. Levi M., de Boer J.P., Roem D., ten Cate J.W., and Hack C.E. Plasminogen activation in vivo upon intravenous infusion of DDAVP: quantitative assessment of plasmin-α2-antiplasmin complexes with a novel monoclonal antibody based radioimmunoassay. Thromb Haemost 67 (1992) 111-116
11. Chavakis T., Willuweit A.K., Lupu F., Preissner K.T., and Kanse S.M. Release of soluble urokinase receptor from vascular cells. Thromb Haemost 86 (2001) 686-693
12. Sier C.F.M., Stephens R., Bizik J., Mariani A., Bassan M., Pedersen N., et al. The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. Cancer Res 58 (1998) 1843-1849
13. Mizukami I.F., Faulkner N.E., Gyetko M.R., Sitrin R.G., and Todd R.F. Enzyme-linked immunoabsorbent assay detection of a soluble form of urokinase plasminogen activator receptor in vivo. Blood 86 (1995) 203-211
14. Higazi A.A.-R., Bdeir K., Hiss E., Arad S., Kuo A., Barghouti I., et al. Lysis of plasma clots by urokinase-soluble urokinase receptor complexes. Blood 92 (1998) 2075-2083
15. Higazi A.A.-R., Mazar A., Wang J., Reilly R., Henkin J., Kniss D., et al. Single chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1. Blood 87 (1996) 3545-3549
16. Bdeir K., Murciano J.-C., Tomaszewski J., Koniaris L., Martinez J., Douglas B., et al. Urokinase mediates fibrinolysis in the pulmonary microvasculature. Blood 96 (2000) 1820-1826